TRT and Cardiovascular Risk: What We Monitor

“Is TRT safe for my heart?”

It’s an important question — and one that deserves a clear, evidence-based answer.

Testosterone therapy is not a casual treatment. It is structured hormone management that requires appropriate patient selection and ongoing monitoring.

What Does the Research Say?

Earlier observational studies raised concerns about cardiovascular risk. However, more recent large randomized trials and meta-analyses have not demonstrated an increased risk of heart attack, stroke, or cardiovascular death in appropriately selected men with hypogonadism.

That said, testosterone therapy is not risk-free — and it should never be prescribed without a monitoring plan.

Safety depends on:

• Proper diagnosis

• Cardiovascular risk assessment

• Ongoing lab surveillance

• Avoiding therapy in high-risk individuals

Why Cardiovascular Monitoring Matters

Testosterone affects multiple physiologic systems, including:

• Red blood cell production

• Lipid metabolism

• Vascular tone

• Fluid balance

In some men, testosterone can increase hematocrit (red blood cell concentration). If hematocrit rises too high, blood viscosity increases, which may elevate cardiovascular risk.

That is why monitoring is essential.

What We Monitor During TRT

A structured TRT program should include:

Hematocrit and HemoglobinTo screen for erythrocytosis. Therapy is adjusted if levels rise excessively.

Lipid ProfileHDL may decrease modestly in some patients. Overall cardiovascular risk profile matters more than a single lipid value.

Blood PressureTestosterone can influence fluid balance and vascular tone.

PSA and Prostate ScreeningTo monitor prostate health.

A1C and Metabolic MarkersBecause insulin resistance and metabolic syndrome strongly influence cardiovascular outcomes.

TRT should never be “prescribe and forget.” It requires ongoing evaluation.

Who Should Not Start TRT Immediately?

Testosterone therapy is generally avoided or delayed in men with:

• Recent myocardial infarction or stroke

• Uncontrolled heart failure

• Untreated severe sleep apnea

• Elevated hematocrit

• Active prostate cancer

Proper screening before initiation reduces risk.

The Bigger Picture: Hormones and Heart Health

Low testosterone itself is often associated with:

• Increased visceral fat

• Insulin resistance

• Metabolic syndrome

• Reduced muscle mass

The relationship between testosterone and cardiovascular health is complex. Both low and excessively high levels may carry risk. The goal is physiologic optimization — not supraphysiologic dosing.

Our Approach

At our clinic, cardiovascular assessment is built into every testosterone evaluation.

Before starting therapy, we evaluate:

• Baseline cardiometabolic risk

• Blood pressure

• Lipid profile

• Glycemic markers

• Hematocrit

After starting therapy, we repeat labs at structured intervals and adjust dosing carefully.

Testosterone therapy should be medically supervised — not driven by symptoms alone.

When properly diagnosed, appropriately dosed, and carefully monitored, TRT can be part of a comprehensive men’s health strategy.